Posted by Michael Wonder on 05 Sep 2017
Introduction of mandatory arrangements for PBS Efficient Funding of Chemotherapy claims
5 September 2017 - From 1 December 2017, approved suppliers will be required to enter a compounder ID when submitting claims for eligible PBS efficient funding of chemotherapy items through PBS Online. Claims submitted without a compounder ID will not be paid.
Currently approved suppliers have the option to select the ‘ZZZ001’ compounder ID code where the compounder ID is unknown. From 1 December 2017, this code will no longer be available. Approved Suppliers will need to ensure they know their compounder ID prior to submitting a claim.
New payment arrangements to TGA-licensed compounders will commence on 1 December 2017. The $20 component of the compounding fee will be paid based on the compounder ID included within each eligible PBS efficient funding of chemotherapy infusible item.
